Please find here an overview of guidance documents currently under development, either proposed or endorsed by ESCMID or its study groups.

The status of each project is defined based on the steps of the GIN-McMaster Guideline Development Checklist.

For more information please contact us at guidancedocuments[at]escmid.org.

  • ESCMID Consensus document for management of COVID-19 in immunocompromised patients

 

Chair: Michele Bartoletti

 

Approval date: May 2022

 

Satus (date): Priority setting (October 2022)

 

  • the Update of the 2014 ESCMID guidelines for the management of the infection prevention & control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients (ESCMID)

 

Chair: Evelina Tacconelli

 

Approval date: December 2020

 

Status (date): Data extraction (April 2022)

 

  • Diagnosis and treatment of brain abscess (ESCMID)

 

Chair: Jacob Bodilsen

 

Approval date: December 2020

 

Status (date): Deciding what evidence to include and searching for evidence (October 2022)

 

  • Antibiotic surgical prophylaxis regimens among patients colonised by MDR-GPB (ESCMID)

 

Chair: Nico T. Mutters

 

Approval date: December 2019

 

Status (date): Reporting and Peer review (October 2022)

 

  • Antimicrobial stewardship in the emergency department (ESCMID)

 

Chair: Jeroen Schouten

 

Approval date: December 2019

 

Status (date): Data Extraction (April 2022)

 

  • Influenza management and treatment (ESCMID)

 

Chair: Barbara Rath

 

Approval date: December 2019

 

Status (date): (PICO) Question Generation (January 2023)

 

  • Management of uncomplicated urinary tract infections (IDSA/ESCMID)

 

ESCMID representative: Angela Huttner

 

Approval date: April 2019

 

Status (date): Deciding what evidence to include and searching for evidence (October 2022)

 

  • Microbiological diagnosis of bloodstream infections (ESCMID/ESA)

 

Chair: Brigitte Lamy

 

Approval date: November 2018

 

Status (date): Literature search (April 2022)

 

  • Diagnosis and management of infective encephalitis (ESCMID/EAN)

 

ESCMID representative: Thomas Whitfield

 

Approval date: April 2018

 

Status (date): Deciding what evidence to include and searching for evidence (October 2022)

 

  • Rituals and behaviors in the operating room (ESCMID/HIS)

 

ESCMID representative: Gemma Marsden

 

Approval date: March 2018

 

Status (date): Reporting and Peer review (January 2023)

 

  • Management of severe community-acquired pneumonia (ERS/ALAT/ESCIM/ESCMID endorsement)

 

ESCMID representative: Matteo Bassetti

 

Approval date: October 2017

 

Status (date): PCP concluded, near publication (October 2022)

 

  • Management of Staphylococcus aureus bacteremia (IDSA/ESCMID)

 

ESCMID representative: Winfried Kern & François Vandenesch.

 

Approval date: January 2017

 

Status (date): Deciding what evidence to include and searching for evidence (September 2022)